Novel Therapy of Hyperhomocysteinemia in Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementing Disorders.
about
Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.Exploring the Association between Alzheimer's Disease, Oral Health, Microbial Endocrinology and Nutrition.B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.Folate Protects Hepatocytes of Hyperhomocysteinemia Mice From Apoptosis via Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Activated Endoplasmic Reticulum Stress.
P2860
Novel Therapy of Hyperhomocysteinemia in Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementing Disorders.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@en
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@nl
type
label
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@en
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@nl
prefLabel
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@en
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@nl
P2093
P2860
P1476
Novel Therapy of Hyperhomocyst ...... and Other Dementing Disorders.
@en
P2093
L W Barrentine
M V Curole
W R Shankle
P2860
P2888
P304
P356
10.1007/S12603-016-0688-Z
P577
2016-01-01T00:00:00Z